SCANDMEDICAL SOLDK-040 (Germany) Market Value

K41 Stock   0.60  0.02  3.45%   
SCANDMEDICAL SOLDK-040's market value is the price at which a share of SCANDMEDICAL SOLDK-040 trades on a public exchange. It measures the collective expectations of SCANDMEDICAL SOLDK 040 investors about its performance. SCANDMEDICAL SOLDK-040 is trading at 0.6 as of the 20th of July 2025. This is a 3.45% up since the beginning of the trading day. The stock's lowest day price was 0.55.
With this module, you can estimate the performance of a buy and hold strategy of SCANDMEDICAL SOLDK 040 and determine expected loss or profit from investing in SCANDMEDICAL SOLDK-040 over a given investment horizon. Check out SCANDMEDICAL SOLDK-040 Correlation, SCANDMEDICAL SOLDK-040 Volatility and SCANDMEDICAL SOLDK-040 Alpha and Beta module to complement your research on SCANDMEDICAL SOLDK-040.
Symbol

Please note, there is a significant difference between SCANDMEDICAL SOLDK-040's value and its price as these two are different measures arrived at by different means. Investors typically determine if SCANDMEDICAL SOLDK-040 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SCANDMEDICAL SOLDK-040's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

SCANDMEDICAL SOLDK-040 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SCANDMEDICAL SOLDK-040's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SCANDMEDICAL SOLDK-040.
0.00
04/21/2025
No Change 0.00  0.0 
In 2 months and 31 days
07/20/2025
0.00
If you would invest  0.00  in SCANDMEDICAL SOLDK-040 on April 21, 2025 and sell it all today you would earn a total of 0.00 from holding SCANDMEDICAL SOLDK 040 or generate 0.0% return on investment in SCANDMEDICAL SOLDK-040 over 90 days. SCANDMEDICAL SOLDK-040 is related to or competes with Abbott Laboratories, Edwards Lifesciences, SIVERS SEMICONDUCTORS, INTUITIVE SURGICAL, BANK HANDLOWY, Reliance Steel, and RYOHIN UNSPADR/1. More

SCANDMEDICAL SOLDK-040 Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SCANDMEDICAL SOLDK-040's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SCANDMEDICAL SOLDK 040 upside and downside potential and time the market with a certain degree of confidence.

SCANDMEDICAL SOLDK-040 Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for SCANDMEDICAL SOLDK-040's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SCANDMEDICAL SOLDK-040's standard deviation. In reality, there are many statistical measures that can use SCANDMEDICAL SOLDK-040 historical prices to predict the future SCANDMEDICAL SOLDK-040's volatility.
Hype
Prediction
LowEstimatedHigh
0.030.603.34
Details
Intrinsic
Valuation
LowRealHigh
0.020.503.24
Details
Naive
Forecast
LowNextHigh
0.010.583.31
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.570.590.61
Details

SCANDMEDICAL SOLDK 040 Backtested Returns

SCANDMEDICAL SOLDK-040 appears to be extremely dangerous, given 3 months investment horizon. SCANDMEDICAL SOLDK 040 retains Efficiency (Sharpe Ratio) of 0.0958, which indicates the company had a 0.0958 % return per unit of risk over the last 3 months. We have found thirty technical indicators for SCANDMEDICAL SOLDK-040, which you can use to evaluate the volatility of the entity. Please review SCANDMEDICAL SOLDK-040's Market Risk Adjusted Performance of 0.6707, standard deviation of 2.78, and Semi Deviation of 2.46 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, SCANDMEDICAL SOLDK-040 holds a performance score of 7. The firm owns a Beta (Systematic Risk) of 0.33, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, SCANDMEDICAL SOLDK-040's returns are expected to increase less than the market. However, during the bear market, the loss of holding SCANDMEDICAL SOLDK-040 is expected to be smaller as well. Please check SCANDMEDICAL SOLDK-040's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether SCANDMEDICAL SOLDK-040's current price history will revert.

Auto-correlation

    
  -0.38  

Poor reverse predictability

SCANDMEDICAL SOLDK 040 has poor reverse predictability. Overlapping area represents the amount of predictability between SCANDMEDICAL SOLDK-040 time series from 21st of April 2025 to 5th of June 2025 and 5th of June 2025 to 20th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SCANDMEDICAL SOLDK 040 price movement. The serial correlation of -0.38 indicates that just about 38.0% of current SCANDMEDICAL SOLDK-040 price fluctuation can be explain by its past prices.
Correlation Coefficient-0.38
Spearman Rank Test0.01
Residual Average0.0
Price Variance0.0

SCANDMEDICAL SOLDK 040 lagged returns against current returns

Autocorrelation, which is SCANDMEDICAL SOLDK-040 stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SCANDMEDICAL SOLDK-040's stock expected returns. We can calculate the autocorrelation of SCANDMEDICAL SOLDK-040 returns to help us make a trade decision. For example, suppose you find that SCANDMEDICAL SOLDK-040 has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

SCANDMEDICAL SOLDK-040 regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SCANDMEDICAL SOLDK-040 stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SCANDMEDICAL SOLDK-040 stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SCANDMEDICAL SOLDK-040 stock over time.
   Current vs Lagged Prices   
       Timeline  

SCANDMEDICAL SOLDK-040 Lagged Returns

When evaluating SCANDMEDICAL SOLDK-040's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SCANDMEDICAL SOLDK-040 stock have on its future price. SCANDMEDICAL SOLDK-040 autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SCANDMEDICAL SOLDK-040 autocorrelation shows the relationship between SCANDMEDICAL SOLDK-040 stock current value and its past values and can show if there is a momentum factor associated with investing in SCANDMEDICAL SOLDK 040.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in SCANDMEDICAL Stock

SCANDMEDICAL SOLDK-040 financial ratios help investors to determine whether SCANDMEDICAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SCANDMEDICAL with respect to the benefits of owning SCANDMEDICAL SOLDK-040 security.